Rigel Pharmaceuticals Inc (RIGL)
SG&A Expense Growth
6.50%
Quarterly · Period ending:
RIGL SG&A Expense Growth
Latest reported6.50%period ending
Latest reported6.50%period ending
RIGL Quarterly SG&A Growth (QoQ) (0.00% → 6.50%)
Latest values, visible window
High-resolution chart · PNG
RIGL sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 6.4957% | |
| 2.1973% | |
| 3.6494% | |
| -1.0972% | |
| 5.5638% | |
| -6.1145% | |
| 9.1595% | |
| -3.5797% | |
| -1.4131% | |
| 5.9553% | |
| 8.0222% | |
| -5.5121% | |
| -5.1318% | |
| -13.8101% | |
| 24.2306% | |
| -4.0176% | |
| -1.5328% | |
| 11.7724% | |
| 7.16% | |
| 2.2299% | |
| 1.1618% | |
| 1.3888% | |
| 25.175% | |
| -7.8753% | |
| 2.6587% | |
| 0.6444% | |
| 1.054% | |
| -0.4833% | |
| -8.7085% | |
| -6.6635% | |
| 18.2689% | |
| 5.8462% | |
| 26.5268% | |
| -7.9296% | |
| 84.3966% | |
| 1.624% | |
| 5.5331% | |
| 3.5929% | |
| 56.9329% | |
| -4.5245% | |
| 7.9358% | |
| -6.3122% | |
| 10.4069% | |
| 4.3181% | |
| -13.1015% | |
| -70.528% | |
| 227.3676% | |
| -9.3454% | |
| -2.2299% | |
| 18.6747% | |
| -0.6201% | |
| -4.3949% | |
| -9.3234% | |
| -7.8093% | |
| 8.7126% | |
| -1.3741% | |
| -11.3385% | |
| 1.0671% | |
| 19.9016% | |
| 4.8937% | |
| -15.8325% | |
| -2.6561% | |
| 6.8897% | |
| -2.3658% | |
| -30.8087% | |
| 44.1959% | |
| 1.8661% | |
| 10.3564% | |
| 9.7111% | |
| -17.9208% | |
| -24.7248% | |
| 8.5848% | |
| -3.7053% | |
| 13.1491% | |
| 24.5944% | |
| -5.9371% | |
| 6.6283% | |
| 0.3785% | |
| 4.4963% | |
| 1.672% | |
| -5.5567% | |
| 83.6637% | |
| -19.4798% | |
| -1.3415% | |
| 19.3111% | |
| -22.471% | |
| -0.1078% | |
| 35.142% | |
| -5.7329% | |
| 25.9948% | |
| 6.9875% | |
| 7.4056% | |
| -1.0816% | |
| -4.0113% | |
| -0.5164% | |
| -22.854% | |
| 12.9705% | |
| 18.3535% | |
| 3.7167% | |
| 3.0005% |